Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses.

The 1918 pandemic H1N1 influenza virus and the recently emerged Southeast Asian H5N1 avian influenza virus are unique among influenza A virus isolates in their high virulence for humans and their lethality for a variety of animal species without prior adaptation. Reverse genetic studies have implicated several viral genes as virulence determinants. For both the 1918 and H5N1 viruses, the hemagglutinin and the polymerase complex contribute to high virulence. Non-structural proteins NS1 and PB1-F2, which block host antiviral responses, also influence pathogenesis. Additionally, recent studies correlate high levels of viral replication and induction of strong proinflammatory responses with the high virulence of these viruses. Defining how individual viral proteins promote enhanced replication, inflammation and severe disease will provide insight into the pathogenesis of severe influenza virus infections and suggest novel therapeutic approaches.

[1]  David J. Stevens,et al.  Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors , 2006, Nature.

[2]  D. Swayne,et al.  Pathogenicity of a Hong Kong–Origin H5N1 Highly Pathogenic Avian Influenza Virus for Emus, Geese, Ducks, and Pigeons , 2002, Avian diseases.

[3]  Yi Guan,et al.  Influenza: Emergence and Control , 2004, Journal of Virology.

[4]  P. Palese,et al.  Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic. , 2007, Infectious disorders drug targets.

[5]  C. Basler.  Influenza viruses: basic biology and potential drug targets. , 2007, Infectious disorders drug targets.

[6]  Michael Gale,et al.  Inhibition of Retinoic Acid-Inducible Gene I-Mediated Induction of Beta Interferon by the NS1 Protein of Influenza A Virus , 2006, Journal of Virology.

[7]  David E. Swayne,et al.  Pathogenicity of Influenza Viruses with Genes from the 1918 Pandemic Virus: Functional Roles of Alveolar Macrophages and Neutrophils in Limiting Virus Replication and Mortality in Mice , 2005, Journal of Virology.

[8]  R. Krug,et al.  Influenza A virus NS1 protein targetspoly(A)‐binding protein II of the cellular 3′‐end processing machinery , 1999, The EMBO journal.

[9]  A. Pekosz,et al.  The RNA Binding Domain of Influenza A Virus NS1 Protein Affects Secretion of Tumor Necrosis Factor Alpha, Interleukin-6, and Interferon in Primary Murine Tracheal Epithelial Cells , 2007, Journal of Virology.

[10]  Yoshihiro Kawaoka,et al.  The continued pandemic threat posed by avian influenza viruses in Hong Kong. , 2002, Trends in microbiology.

[11]  Michael W. Shaw,et al.  Molecular Correlates of Influenza A H5N1 Virus Pathogenesis in Mice , 2000, Journal of Virology.

[12]  M. Sheng,et al.  PDZ domains and the organization of supramolecular complexes. , 2001, Annual review of neuroscience.

[13]  David E. Swayne,et al.  Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus , 2006, Nature.

[14]  Lucy A. Perrone,et al.  A Single Mutation in the PB1-F2 of H5N1 (HK/97) and 1918 Influenza A Viruses Contributes to Increased Virulence , 2007, PLoS pathogens.

[15]  Youichirou Higashi,et al.  Mitochondrial targeting sequence of the influenza A virus PB1‐F2 protein and its function in mitochondria , 2004, FEBS letters.

[16]  T. Fujita,et al.  NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. , 2007, American journal of respiratory cell and molecular biology.

[17]  R. Webster,et al.  Influenza virus a pathogenicity: The pivotal role of hemagglutinin , 1987, Cell.

[18]  P. Henklein,et al.  Influenza A virus protein PB1‐F2: synthesis and characterization of the biologically active full length protein and related peptides , 2005, Journal of peptide science : an official publication of the European Peptide Society.

[19]  P. Massin,et al.  Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses. , 2000, The Journal of general virology.

[20]  Thijs Kuiken,et al.  Avian H5N1 Influenza in Cats , 2004, Science.

[21]  G. Kochs,et al.  Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein , 2007, Journal of Virology.

[22]  J. Ortín,et al.  Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. , 1996, Nucleic acids research.

[23]  R. Krug,et al.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. , 1998, Molecular cell.

[24]  David E. Swayne,et al.  Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus , 2005, Science.

[25]  R. Krug,et al.  A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. , 2007, Virology.

[26]  H. Klenk,et al.  The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Yi Guan,et al.  Lethality to Ferrets of H5N1 Influenza Viruses Isolated from Humans and Poultry in 2004 , 2005, Journal of Virology.

[28]  R. Krug,et al.  Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. , 2006, Virology.

[29]  T. Tumpey,et al.  Pathogenesis of and immunity to avian influenza A H5 viruses. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[30]  David E. Swayne,et al.  A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission , 2007, Science.

[31]  N. Cox,et al.  A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans , 1999, Journal of Virology.

[32]  Jonathan W. Yewdell,et al.  A novel influenza A virus mitochondrial protein that induces cell death , 2001, Nature Medicine.

[33]  J. Taubenberger,et al.  Characterization of the 1918 "Spanish" influenza virus neuraminidase gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Stefan Hippenstiel,et al.  IFNβ induction by influenza A virus is mediated by RIG‐I which is regulated by the viral NS1 protein , 2007, Cellular microbiology.

[35]  R. Krug,et al.  The active sites of the influenza cap‐dependent endonuclease are on different polymerase subunits , 2001, The EMBO journal.

[36]  D. Levy,et al.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. , 1998, Virology.

[37]  R. Webster,et al.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses , 2002, Nature Medicine.

[38]  R. Webster,et al.  Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus , 1998, The Lancet.

[39]  Y. Honda,et al.  Fine Mapping of the Subunit Binding Sites of Influenza Virus RNA Polymerase , 2002 .

[40]  Niall Johnson,et al.  Updating the Accounts: Global Mortality of the 1918-1920 "Spanish" Influenza Pandemic , 2002, Bulletin of the history of medicine.

[41]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.

[42]  P. Massin,et al.  Residue 627 of PB2 Is a Determinant of Cold Sensitivity in RNA Replication of Avian Influenza Viruses , 2001, Journal of Virology.

[43]  J. Yewdell,et al.  PB1-F2, an Influenza A Virus-Encoded Proapoptotic Mitochondrial Protein, Creates Variably Sized Pores in Planar Lipid Membranes , 2004, Journal of Virology.

[44]  Stephan Ludwig,et al.  The proapoptotic influenza A virus protein PB1‐F2 regulates viral polymerase activity by interaction with the PB1 protein , 2008, Cellular microbiology.

[45]  P. Palese,et al.  Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells , 1977, Journal of virology.

[46]  Roger E Bumgarner,et al.  Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: The role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Webster,et al.  Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection , 2007, Proceedings of the National Academy of Sciences.

[48]  A. Vaheri,et al.  Susceptibility of human cells to Puumala virus infection. , 1993, The Journal of general virology.

[49]  M. Katze,et al.  Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. , 1995, Virology.

[50]  Jin Hyun Kim,et al.  Growth of H5N1 Influenza A Viruses in the Upper Respiratory Tracts of Mice , 2007, PLoS pathogens.

[51]  P. Henklein,et al.  Structural Characterization and Oligomerization of PB1-F2, a Proapoptotic Influenza A Virus Protein* , 2006, Journal of Biological Chemistry.

[52]  Guohua Deng,et al.  A Single-Amino-Acid Substitution in the NS1 Protein Changes the Pathogenicity of H5N1 Avian Influenza Viruses in Mice , 2007, Journal of Virology.

[53]  R. Lamb,et al.  A new influenza virus virulence determinant: The NS1 protein four C-terminal residues modulate pathogenicity , 2008, Proceedings of the National Academy of Sciences.

[54]  Y. Guan,et al.  H5N1 Outbreaks and Enzootic Influenza , 2006, Emerging infectious diseases.

[55]  D. Steinhauer,et al.  Role of hemagglutinin cleavage for the pathogenicity of influenza virus. , 1999, Virology.

[56]  R. Krug,et al.  Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. , 2003, Virology.

[57]  G. Montelione,et al.  RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. , 1999, RNA.

[58]  Rong Wang,et al.  Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1 , 2005, PLoS pathogens.

[59]  G G Brownlee,et al.  Orthomyxovirus replication, transcription, and polyadenylation. , 2004, Current topics in microbiology and immunology.

[60]  H. Goto,et al.  Plasminogen-Binding Activity of Neuraminidase Determines the Pathogenicity of Influenza A Virus , 2001, Journal of Virology.

[61]  R. Lamb,et al.  Influenza Virus Hemagglutinin and Neuraminidase, but Not the Matrix Protein, Are Required for Assembly and Budding of Plasmid-Derived Virus-Like Particles , 2007, Journal of Virology.

[62]  N. Cox,et al.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. , 1998, Science.

[63]  Gunther Hartmann,et al.  5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.

[64]  Lucy A. Perrone,et al.  Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus , 2008, Proceedings of the National Academy of Sciences.

[65]  M. Elizabeth Halloran,et al.  Detecting Human-to-Human Transmission of Avian Influenza A (H5N1) , 2007, Emerging Infectious Diseases.

[66]  A. Fernández-Sesma.  The influenza virus NS1 protein: inhibitor of innate and adaptive immunity. , 2007, Infectious disorders drug targets.

[67]  Y. Guan,et al.  Reemerging H5N1 Influenza Viruses in Hong Kong in 2002 Are Highly Pathogenic to Ducks , 2004, Journal of Virology.

[68]  Jeffery K. Taubenberger,et al.  Characterization of the 1918 influenza virus polymerase genes , 2005, Nature.

[69]  A. Pichlmair,et al.  RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.

[70]  R. Krug,et al.  RNA‐dependent activation of primer RNA production by influenza virus polymerase: different regions of the same protein subunit constitute the two required RNA‐binding sites , 1998, EMBO Journal.

[71]  G. Russ,et al.  Influenza a virus PB1-F2 protein. , 2007, Acta virologica.

[72]  Yoshihiro Kawaoka,et al.  Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses , 2001, Science.

[73]  M. Bray,et al.  Current and future antiviral therapy of severe seasonal and avian influenza , 2008, Antiviral Research.

[74]  J. Peiris,et al.  Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.

[75]  R. Webster,et al.  The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. , 2004, Virus research.

[76]  A. García-Sastre,et al.  Sensing RNA virus infections. , 2007, Nature chemical biology.

[77]  Yoshihiro Kawaoka,et al.  PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. , 2004, Virology.

[78]  P. P. Laidlaw,et al.  A Virus obtained from influenza patients , 1933 .

[79]  A. Gibbs,et al.  Molecular virology: Was the 1918 pandemic caused by a bird flu? Was the 1918 flu avian in origin? (Reply) , 2006, Nature.

[80]  C. Scholtissek,et al.  On the origin of the human influenza virus subtypes H2N2 and H3N2. , 1978, Virology.

[81]  N. Cox,et al.  Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals , 2005, Journal of Virology.

[82]  David E. Levy,et al.  Influenza virus targets the mRNA export machinery and the nuclear pore complex , 2007, Proceedings of the National Academy of Sciences.

[83]  Yong Poovorawan,et al.  Avian Influenza H5N1 in Tigers and Leopards , 2004, Emerging infectious diseases.

[84]  Yoshihiro Kawaoka,et al.  Early Alterations of the Receptor-Binding Properties of H1, H2, and H3 Avian Influenza Virus Hemagglutinins after Their Introduction into Mammals , 2000, Journal of Virology.

[85]  M. Katze,et al.  Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[86]  H. Goto,et al.  Biological Heterogeneity, Including Systemic Replication in Mice, of H5N1 Influenza A Virus Isolates from Humans in Hong Kong , 1999, Journal of Virology.

[87]  R. Krug,et al.  The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Jeffery K. Taubenberger,et al.  Initial Genetic Characterization of the 1918 “Spanish” Influenza Virus , 1997, Science.

[89]  J. Taubenberger,et al.  Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[90]  B. Lambrecht,et al.  Highly Pathogenic H5N1 Influenza Virus in Smuggled Thai Eagles, Belgium , 2005, Emerging infectious diseases.

[91]  J. Taubenberger,et al.  Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[92]  P. Palese,et al.  Influenza A Virus PB1-F2 Protein Contributes to Viral Pathogenesis in Mice , 2006, Journal of Virology.

[93]  J. McCauley,et al.  Deduced amino acid sequences of the haemagglutinin of H5N1 avian influenza virus isolates from an outbreak in turkeys in Norfolk, England , 2005, Archives of Virology.

[94]  Hidekazu Nishimura,et al.  Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus , 2004, Nature.

[95]  Kelli L Boyd,et al.  Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. , 2007, Cell host & microbe.

[96]  J. Taubenberger,et al.  Molecular virology: Was the 1918 pandemic caused by a bird flu? Was the 1918 flu avian in origin? (Reply) , 2006, Nature.

[97]  Y. Kawaoka,et al.  Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses , 1994, Journal of virology.

[98]  H. Goto,et al.  A novel mechanism for the acquisition of virulence by a human influenza A virus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[99]  M. Peiris,et al.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus , 1998, The Lancet.

[100]  J. Paulson,et al.  Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. , 1983, Virology.

[101]  N. Cox,et al.  Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice. , 2007, Virus research.

[102]  R. Webster,et al.  Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics , 1989, Journal of virology.

[103]  P. Palese,et al.  Influenza A virus PB1-F2: a small protein with a big punch. , 2007, Cell host & microbe.

[104]  R. M. Marión,et al.  Protein Synthesis Shut-Off Induced by Influenza Virus Infection Is Independent of PKR Activity , 2000, Journal of Virology.

[105]  J. Taubenberger,et al.  1918 Influenza: the Mother of All Pandemics , 2006, Emerging infectious diseases.

[106]  T. Francis.  TRANSMISSION OF INFLUENZA BY A FILTERABLE VIRUS. , 1934, Science.

[107]  Thijs Kuiken,et al.  H5N1 Virus Attachment to Lower Respiratory Tract , 2006, Science.

[108]  Zejun Li,et al.  The NS1 Gene Contributes to the Virulence of H5N1 Avian Influenza Viruses , 2006, Journal of Virology.

[109]  M. Vey,et al.  Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin‐like endoprotease. , 1992, The EMBO journal.

[110]  A. Virus.  Update: isolation of avian influenza A(H5N1) viruses from humans--Hong Kong, 1997-1998. , 1998, MMWR. Morbidity and mortality weekly report.

[111]  C. Naeve,et al.  Large-Scale Sequence Analysis of Avian Influenza Isolates , 2006, Science.

[112]  J. Taubenberger,et al.  Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[113]  J. Taubenberger,et al.  The 1918 Spanish influenza: integrating history and biology. , 2001, Microbes and infection.

[114]  Yan Li,et al.  Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus , 2007, Nature.

[115]  P. Palese,et al.  Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus , 1993, Journal of virology.

[116]  David E. Swayne,et al.  Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[117]  Y. Kawaoka,et al.  Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus , 1994, Journal of virology.

[118]  Christine A. Biron,et al.  Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente , 2006, Science.

[119]  R. Lamb,et al.  Orthomyxoviridae: The Viruses and Their Replication. , 1996 .

[120]  Yoshihiro Kawaoka,et al.  Avian flu: Influenza virus receptors in the human airway , 2006, Nature.

[121]  H. Klenk,et al.  Functional balance between haemagglutinin and neuraminidase in influenza virus infections , 2002, Reviews in medical virology.

[122]  T. Tumpey,et al.  Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice , 2006, Journal of Virology.

[123]  Jonathan W. Yewdell,et al.  The Influenza A Virus PB1-F2 Protein Targets the Inner Mitochondrial Membrane via a Predicted Basic Amphipathic Helix That Disrupts Mitochondrial Function , 2003, Journal of Virology.